New pain pill enters first human safety tests
Symptom relief
Not yet recruiting
This early-stage trial will test the safety and tolerability of a new experimental drug called IG001119 in 64 healthy volunteers. Participants will receive either the drug or a placebo tablet. The study aims to understand how the drug behaves in the body and identify any side eff…
Phase: PHASE1 • Sponsor: Iongen Therapeutics Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC